Oxytocin

Neuropeptide hormone · Also known as Pitocin (injectable), Syntocinon (nasal), the love hormone, the bonding hormone

What is oxytocin?

A 9-amino-acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary gland. It plays central roles in social bonding, trust, empathy, sexual function, and childbirth. The injectable form (Pitocin) is FDA-approved for labor induction.

Oxytocin was first synthesized in 1953 by Vincent du Vigneaud, earning him the Nobel Prize. Its role in labor and breastfeeding has been known for over a century, but research over the past two decades has expanded into social cognition, anxiety, autism, and pair bonding. It is one of the most studied neuropeptides, with hundreds of clinical trials using intranasal delivery to explore effects on social behavior and psychiatric conditions.

Key takeaway: Oxytocin is an FDA-approved hormone with extensive clinical data for labor induction and breastfeeding support, plus growing (but mixed) evidence for intranasal use in social cognition and autism spectrum disorder.

Benefits & evidence

Labor induction and postpartum hemorrhage control High confidence
Breastfeeding / milk let-down support High confidence
Social cognition enhancement Moderate confidence
Anxiety reduction Moderate confidence
Autism social function (intranasal) Preliminary confidence
Pair bonding / relationship support Preliminary confidence

How it works

Oxytocin binds to oxytocin receptors (OXTRs) distributed throughout the brain and body. In the central nervous system, it modulates neural circuits involved in social recognition, trust, empathy, and anxiety reduction. It influences the amygdala (reducing fear responses), the reward system (reinforcing social bonding), and the hypothalamic-pituitary-adrenal axis (lowering stress hormone output).

When delivered intranasally, oxytocin reaches the brain through direct nose-to-brain transport along olfactory and trigeminal nerve fibers, as well as through peripheral circulation and vagal stimulation. The effects are dose-dependent, with research suggesting that lower doses (8 IU) may sometimes produce stronger social-cognitive effects than higher doses (24 IU). In peripheral tissues, oxytocin causes uterine contractions and milk let-down, which are the basis for its FDA-approved obstetric uses.

Dosing information

Typical dosing protocol
Starting dose

20 IU intranasal

Single dose or short-term use
Maintenance dose

24 IU intranasal 1-2x/day

Varies by indication (weeks to months in clinical trials)

Intranasal doses of 18-40 IU have been used safely in controlled research settings with no reliable side effects for short-term use. For labor induction, Pitocin is given IV in hospital settings only (0.5-2 mU/min, titrated). Some research suggests lower intranasal doses (8 IU) may be more effective than higher doses for social-cognitive effects. Intranasal oxytocin is available as a compounded prescription.

Side effects

Most side effects tend to improve as your body adjusts.

Nasal irritation (intranasal) Common
Headache Common
Nausea Moderate
Uterine cramping Moderate
Blood pressure changes (IV use) Moderate
Uterine hyperstimulation (IV, high doses) Rare
Water intoxication (prolonged IV infusion) Rare

Research (10 studies)

Nomogram for predicting HIFU efficacy in uterine fibroids: based on oxytocin-induced arterial-phase perfusion delay and ultrasound features. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2026